Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (201-210 of 424) with videos related to

Pageof 43
Sort By:
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1986
The "all in one" system for TPN causes increased rates of catheter blockadeH R Freund, B Rimon, M Muggia-Sullam, et al.
Israel Journal of Medical Sciences|September 1, 1980
Pancreatic abscess and its relation to biliary tract diseaseA Ayalon, M Muggia-Sullam, A L Durst, et al.
Injury|July 1, 1981
Repair of the injured spleenS Katz, Y Berlatzky, M Muggia, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2001
Follow-up imaging studies of blunt splenic injury: do they influence management?S Lyass, T Sela, P D Lebensart, et al.
Cancer Investigation|January 1, 1989
Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndromeA Chachoua, M D Green, F Valentine, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Cancer Treatment Reports|April 1, 1984
Activity of mitolactol in cancer of the uterine cervixV Lira-Puerto, F Morales-Canfield, J Wernz, et al.
Pageof 43

Showing results (201-210 of 424) with videos related to

Sort By:
Pageof 43
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1986
The "all in one" system for TPN causes increased rates of catheter blockadeH R Freund, B Rimon, M Muggia-Sullam, et al.
Israel Journal of Medical Sciences|September 1, 1980
Pancreatic abscess and its relation to biliary tract diseaseA Ayalon, M Muggia-Sullam, A L Durst, et al.
Injury|July 1, 1981
Repair of the injured spleenS Katz, Y Berlatzky, M Muggia, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2001
Follow-up imaging studies of blunt splenic injury: do they influence management?S Lyass, T Sela, P D Lebensart, et al.
Cancer Investigation|January 1, 1989
Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndromeA Chachoua, M D Green, F Valentine, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Cancer Treatment Reports|April 1, 1984
Activity of mitolactol in cancer of the uterine cervixV Lira-Puerto, F Morales-Canfield, J Wernz, et al.
Pageof 43